Wayne Finlayson

Executive Director CEO

Wayne has wide-ranging scientific and commercial corporate experience in the biopharmaceutical and biotechnology sector, stretching over 30 years. His sound knowledge and understanding of the sector internationally include regulatory structures and requirements. During his career, Wayne developed strong skills and experience in the commercialisation of technology and the practical application of science for the creation of sustainable commercial enterprises. He progressed from initial roles focusing on pure science to management positions, including General Manager and Managing Director/CEO.

Positions held include that of Executive Director of Infergene (listed on NASDAQ), with specific responsibility for technology. In 1990, Wayne founded Progen Pharmaceuticals and was Managing Director and CEO. After leaving Progen Pharmaceuticals, he acted as a consultant until 2009, providing technology investment advice to clients. During this period, he also held various contract positions for clients (including large investment firms in the USA), with responsibility for ensuring readiness of investee companies for public listing or other investment.

Wayne holds a BSc (Hons) and a PhD in Organic Chemistry from La Trobe University. After completing his doctorate, he was a post-doctoral Research Fellow for three years at the University of California, Berkeley, in the USA.